Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1526 ARTÍCULOS , VIENDO DEL 1516 AL 1526

A systematic review and meta-analysis of the associations of vitamin D receptor genetic variants with two types of most common neurodegenerative disorders

Geng J, Zhang J, Yao F, Liu X, Liu J, Huang Y.

Aging Clin Exp Res. 2020 Jan;32(1):21-27. doi: 10.1007/s40520-019-01135-4. Epub 2019 Mar 12.

Mammalian cystatin and protagonists in brain diseases

Amin F, Khan MS, Bano B.

J Biomol Struct Dyn. 2020 Apr;38(7):2171-2196. doi: 10.1080/07391102.2019.1620636. Epub 2019 Jun 5.

Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders

Reddy AP, Ravichandran J, Carkaci-Salli N.

Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165506. doi: 10.1016/j.bbadis.2019.06.020. Epub 2019 Jul 2.

Chinese patients with Lewy body dementia had shorter survival and developed complications earlier than those with Alzheimer's disease

Shea YF, Lee SC, Shum ACK, Chiu PK, Chu LW, Chan HWF.

Singapore Med J. 2020 Oct;61(10):551-558. doi: 10.11622/smedj.2019103. Epub 2019 Sep 6.

Noradrenergic pathways of locus coeruleus in Parkinson's and Alzheimer's pathology

Singh S.

Int J Neurosci. 2020 Mar;130(3):251-261. doi: 10.1080/00207454.2019.1667799. Epub 2019 Oct 13.

Italian consensus recommendations for a biomarker-based aetiological diagnosis in mild cognitive impairment patients

Boccardi M, Nicolosi V, Festari C, Bianchetti A, Cappa S, Chiasserini D, Falini A, Guerra UP, Nobili F, Padovani A, Sancesario G, Morbelli S, Parnetti L, Tiraboschi P, Muscio C, Perani D, Pizzini FB, Beltramello A, Salvini Porro G, Ciaccio M, Schillaci O, Trabucchi M, Tagliavini F, Frisoni GB.

Eur J Neurol. 2020 Mar;27(3):475-483. doi: 10.1111/ene.14117. Epub 2019 Dec 18.

GIP has neuroprotective effects in Alzheimer and Parkinson's disease models

Zhang ZQ, Hölscher C.

Peptides. 2020 Mar;125:170184. doi: 10.1016/j.peptides.2019.170184. Epub 2019 Nov 6.

Modifying the progression of Alzheimer's and Parkinson's disease with deep brain stimulation

Jakobs M, Lee DJ, Lozano AM.

Neuropharmacology. 2020 Jul;171:107860. doi: 10.1016/j.neuropharm.2019.107860. Epub 2019 Nov 23.

The microbiome-gut-brain axis in acute and chronic brain diseases

Benakis C, Martin-Gallausiaux C, Trezzi JP, Melton P, Liesz A, Wilmes P.

Curr Opin Neurobiol. 2020 Apr;61:1-9. doi: 10.1016/j.conb.2019.11.009. Epub 2019 Dec 6.

Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases

Wang Y, Yang Y, Zhang S, Li C, Zhang L.

Neurobiol Aging. 2020 Mar;87:1-10. doi: 10.1016/j.neurobiolaging.2019.12.013. Epub 2019 Dec 20.

Pharmacogenomics of Alzheimer's and Parkinson's diseases

Cacabelos R.

Neurosci Lett. 2020 May 1;726:133807. doi: 10.1016/j.neulet.2018.09.018. Epub 2018 Sep 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias